Y Intercept (Hong Kong) LTD Genmab A/S Transaction History
Y Intercept (Hong Kong) LTD
- $3.75 Billion
- Q2 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Genmab A/S stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 29,329 shares of GMAB stock, worth $815,932. This represents 0.02% of its overall portfolio holdings.
Number of Shares
29,329
Previous 32,476
9.69%
Holding current value
$815,932
Previous $635,000
4.72%
% of portfolio
0.02%
Previous 0.05%
Shares
13 transactions
Others Institutions Holding GMAB
# of Institutions
241Shares Held
65.1MCall Options Held
32.5KPut Options Held
55K-
Alliancebernstein L.P. New York, NY10.7MShares$297 Million0.08% of portfolio
-
Orbis Allan Gray LTD Hamilton, D07.92MShares$220 Million1.07% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$141 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.57MShares$99.3 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA3.45MShares$96.1 Million0.05% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $18.3B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...